Product Details

CALQUENCE 100MG TAB 60/EA

Manufacturer: ASTRAZENECA

MFG#: 310351260

NDC: 310351260

PID: 423239

This product is not currently available, please contact us for further information.

Additional Information

Product NameCalquence 100Mg Tab 60/Ea
Active IngredientAcalabrutinib
Mechanism of ActionIrreversibly binds to BTK, inhibiting B-cell receptor signaling to reduce malignant B-cell proliferation
Dosage FormOral Tablet
Strength100 mg
Administration InstructionsSwallow whole with water, avoid grapefruit and Seville oranges
Dosing FrequencyTwice daily (every 12 hours)
Common Side EffectsHeadache, diarrhea, fatigue, musculoskeletal pain, upper respiratory tract infections
Serious Adverse EffectsAtrial fibrillation, major bleeding, infections, cytopenias
Monitoring RequirementsBlood counts, signs of bleeding, cardiac arrhythmias, infection risk
Storage ConditionsStore at controlled room temperature, protect from moisture
PackagingBottle containing 60 tablets
IndicationsChronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma (MCL)

Description

Calquence (acalabrutinib) 100 mg tablets are a Bruton's tyrosine kinase (BTK) inhibitor indicated for the treatment of certain hematologic malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL) in patients who have received at least one prior therapy. By selectively inhibiting BTK, Calquence disrupts B-cell receptor signaling, reducing the proliferation and survival of malignant B cells.

The mechanism of action involves irreversible binding to BTK, which blocks downstream signaling pathways essential for B-cell activation and survival. This inhibition decreases tumor cell growth and improves disease control. Calquence is administered orally and may be used as monotherapy or in combination with other agents, depending on the specific indication.

Common adverse effects include headache, diarrhea, fatigue, musculoskeletal pain, and upper respiratory tract infections. Serious risks include atrial fibrillation, bleeding, infections, and cytopenias. Patients should be monitored for signs of bleeding, cardiac arrhythmias, and immune suppression.

Frequently Asked Questions (FAQs)

The cost of CALQUENCE 100MG TAB 60/EA is $available for registerd members only

CALQUENCE 100MG TAB 60/EA is manufactured by ASTRAZENECA.

You can purchase CALQUENCE 100MG TAB 60/EA on our website at https://supplies.pipelinemedical.com/product/detail/calquence-100mg-tab-60-ea-423239